Want to see AU:CTE full AI Analyst Report?
CTE Stock Chart & Stats
AU$1.25
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$1.25
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.76 - AU$1.65
Previous CloseN/A
Volume13.31K
Average Volume (3M)587.00
Market Cap
AU$61.01M
Enterprise ValueAU$70.71
Total Cash (Recent Filing)AU$2.24M
Total Debt (Recent Filing)AU$7.72M
Price to Earnings (P/E)27.3
Beta-0.17
Next Earnings
Feb 25, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield9.33%
Share Statistics
EPS (TTM)0.05
Shares Outstanding48,809,563
10 Day Avg. Volume1,356
30 Day Avg. Volume587
Financial Highlights & Ratios
PEG Ratio1.46
Price to Book (P/B)12.58
Price to Sales (P/S)3.65
P/FCF Ratio-7.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthThe sustained increase in revenue indicates expanding demand for Cryosite’s temperature-controlled life-sciences logistics and storage services, supporting a larger operating base and providing a durable foundation for future earnings growth.
Operating ProfitabilityHealthy operating and EBITDA margins show that the company can convert specialized logistics activity into meaningful profit. Continued positive earnings and operating leverage strengthen internal funding capacity and business resilience.
Positive Operating Cash FlowImproving operating cash generation provides evidence that the core business produces cash, not just accounting earnings. This supports ongoing operations and can help fund investment, although conversion remains below net income.
Bears Say
Higher Financial LeverageThe sharp increase in debt reduces financial flexibility for a relatively small company and raises sensitivity to operating setbacks. Higher leverage may constrain investment choices and increase dependence on sustained earnings and cash generation.
Negative Free Cash FlowThe reversal to deeply negative free cash flow suggests substantial investment or other cash outflows that are not currently covered by operations. If persistent, this could increase funding needs and amplify the risks created by higher debt.
Gross Margin CompressionLower gross margin indicates rising direct costs or a less favorable service mix, potentially limiting the sustainability of profitability. Although operating margins remain healthy, continued pressure could weaken future earnings and cash conversion.
Cryosite Limited News
CTE FAQ
What was Cryosite Limited’s price range in the past 12 months?
Cryosite Limited lowest share price was AU$0.76 and its highest was AU$1.65 in the past 12 months.
What is Cryosite Limited’s market cap?
Cryosite Limited’s market cap is AU$61.01M.
When is Cryosite Limited’s upcoming earnings report date?
Cryosite Limited’s upcoming earnings report date is Feb 25, 2027 which is in 170 days.
How were Cryosite Limited’s earnings last quarter?
Cryosite Limited released its earnings results on Aug 18, 2026. The company reported AU$0.022 earnings per share for the quarter.
Is Cryosite Limited overvalued?
According to Wall Street analysts Cryosite Limited’s price is currently Overvalued.
Does Cryosite Limited pay dividends?
Cryosite Limited pays a Semiannually dividend of AU$0.02 which represents an annual dividend yield of 9.33%. See more information on Cryosite Limited dividends here
What is Cryosite Limited’s EPS estimate?
Cryosite Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cryosite Limited have?
Cryosite Limited has 48,809,563 shares outstanding.
What happened to Cryosite Limited’s price movement after its last earnings report?
Cryosite Limited reported an EPS of AU$0.022 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cryosite Limited?
Currently, no hedge funds are holding shares in AU:CTE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cryosite Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
45.34%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
33.43%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cryosite Limited
Cryosite Limited, founded in 1999 and headquartered in South Granville, Australia, specializes in providing outsourced logistics and storage solutions to the life sciences industry within Australia. The company operates through two distinct divisions. Its Clinical Trials and Biological Services Logistics segment offers comprehensive support to the clinical research and pharmaceutical sectors, encompassing services such as specialized temperature-controlled and general biological storage, precise labeling, secondary packaging, and end-to-end supply chain management capabilities like scheduled drug distribution, returns processing, material destruction, status oversight, comparator sourcing, and validated import/export and transportation. The second division, Cord Blood and Tissues Storage, focuses on the long-term cryogenic preservation of cord blood and tissue samples. Cryosite's client base spans the research, medical, pharmaceutical, veterinary, and biotechnology industries.
Technical Analysis
Healius Limited
―
Genetic Signatures Ltd.
―
Sonic Healthcare Limited
―
Australian Clinical Labs Ltd
―
Monash IVF Group Ltd
―